CHANNEL BY TOPICS

QUICK LINKS

Research and Markets: United States Market for In Vitro Diagnostic Tests Report 2014-2018

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/npt9tk/the_united_states)
has announced the addition of the "The
United States Market for In Vitro Diagnostic Tests" report to
their offering.

Advanced flow cytometry and microbiology tests will provide more
opportunity for manufacturers than POC tests or clinical chemistry test
products sold in the United States. A Relative Opportunity Metric is
used to assess the segments of clinical lab testing in the world's
largest healthcare market.

According to the report, Market growth remains robust for U.S.
microbiology diagnostics, a group of IVD segments including traditional
microbiology (culturing for ID/AST), rapid tests, molecular infectious
disease tests, and immunoassay infectious disease tests. Several market
drivers exist for microbiology in the United States: hospital investment
i microbiology for health-acquired infection (HAI) testing, investment
in automated microbiology systems, rising rates of incidence for several
sexually transmitted diseases (STDs), and market penetration by
higher-priced molecular infectious disease tests.

The report also indicates that advanced IVD tests in this study,
including molecular assays for non-infectious disease testing,
histology, cytology, and flow cytometry. Molecular assays and histology
are projected to be the two-fastest growing IVD market segments in the
United States through 2018. Tissue analysis or histology in support of
cancer diagnosis and treatment is increasingly reliant on
immunohistochemical (IHC) reagents and molecular hybridization
(ISH/FISH) techniques and represents a fast rising market in the aging
United States. The United States is also ground zero for an influx of
advanced molecular assays for blood-based cancer testing, circulating
tumor cell (CTC (News - Alert)) testing, pharmacodiagnostics, and other
sequencing-developed tests.

The report, The United States Market for In Vitro Diagnostic Tests,
contains further detail on the US IVD market including segment markets
and forecasts, corporate profiles, and other information.

Key Topics Covered:

Chapter One: Executive Summary

Chapter Two: Introduction To U.S. Health Care

Chapter Three: U.S. Ivd Market Analysis

Chapter Four: Top Tier U.S. Ivd Market Players

Abbott Diagnostics

Alere

Beckman Coulter

Becton Dickinson

Danaher Corporation (News - Alert)

Hologic

Ortho-Clinical Diagnostics / J&J Diabetes Care

QIAGEN

Roche Diagnostics

Siemens (News - Alert) Healthcare Diagnostics

Sysmex Corporation

Thermo Fisher Scientific

For more information visit http://www.researchandmarkets.com/research/npt9tk/the_united_states